EPIDUO

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, United States

Active ingredients

The drug EPIDUO contains a combination of these active pharmaceutical ingredients (APIs):

1 Adapalene
UNII 1L4806J2QF - ADAPALENE

Adapalene is a retinoid-like compound which in, in vivo and in vitro models of inflammation, has been demonstrated to possess anti-inflammatory properties. Mechanically, adapalene binds like tretinoin to specific retinoic acid nuclear receptors but, unlike tretinoin not to cytosolic receptor binding proteins. Adapalene is used in the treatment of acne and is also used (off-label) to treat keratosis pilaris as well as other skin conditions.

Read about Adapalene
2 Benzoyl peroxide
UNII W9WZN9A0GM - BENZOYL PEROXIDE

Benzoyl peroxide is a highly lipophilic, oxidising agent with keratolytic and bacteriocidal effects. The effectiveness of benzoyl peroxide in the treatment of acne vulgaris is primarily attributable to its antibacterial activity, especially with respect to Propionibacterium acnes. Benzoyl peroxide is also believed to be effective in the treatment of acne on account of its anti-inflammatory and mild keratolytic properties.

Read about Benzoyl peroxide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
EPIDUO Gel Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D10AD53 Adapalene, combinations D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AD Retinoids for topical use in acne
Discover more medicines within D10AD53

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 8954G, 8955H
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 510102001171319, 510102003172312
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 29314-07-10, 3280-MEE-0618
Country: EE Ravimiamet Identifier(s): 1731877, 1731888, 1731899, 1731901, 1731912, 1731923
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 69445, 81359
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 029839, 114687, 114698, 386977, 408675, 491468
Country: FR Base de données publique des médicaments Identifier(s): 60972530, 64950392
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 243938, 380227
Country: HK Department of Health Drug Office Identifier(s): 58988, 66483
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-671525095, HR-H-673699134
Country: IE Health Products Regulatory Authority Identifier(s): 21002
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8943, 9374
Country: JP 医薬品医療機器総合機構 Identifier(s): 2699805Q1020
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1082748, 1082749, 1082750, 1082751, 1082752, 1082753, 1082754, 1082755, 1082756, 1082757
Country: MT Medicines Authority Identifier(s): MA117/01202, MA117/01203
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 14153
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100192249, 100377380
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W63540001, W63540002, W63540003, W63540004, W63540005, W63540006, W63540007, W63540008, W63540009, W63540010, W69284001, W69284002, W69284003, W69284004, W69284005, W69284006, W69284007, W69284008, W69284009, W69284010
Country: SG Health Sciences Authority Identifier(s): 13789P, 15460P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 7393091, 7393111
Country: US FDA, National Drug Code Identifier(s): 0299-5906, 0299-5908

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.